BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 863373)

  • 1. [Medical therapy of the metastasizing breast neoplasm].
    Hartenstein R; Ehrhart H; Pape W
    Fortschr Med; 1977 May; 95(19):1305-12. PubMed ID: 863373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of breast cancer.
    Cohen IA; Keller JH; Abate MA
    Clin Pharm; 1982; 1(6):515-29. PubMed ID: 6192963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormones and tumor therapy: current clinical status and future developments in endocrine therapy of breast cancer].
    Szepesi T; Schratter-Sehn AU
    Wien Klin Wochenschr; 1982 Sep; 94(17):463-9. PubMed ID: 6760557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medical considerations on the treatment of metastasizing mammary carcinoma (author's transl)].
    Lissner J; Kessler M
    MMW Munch Med Wochenschr; 1975 Jul; 117(29-30):1233-8. PubMed ID: 51474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced mammary cancer.
    Welbourn RB; Burn JI
    N Engl J Med; 1972 Aug; 287(8):398-400. PubMed ID: 5043525
    [No Abstract]   [Full Text] [Related]  

  • 6. Certain aspects of the medical management of metastatic breast cancer.
    Abeloff MD
    Johns Hopkins Med J; 1974 Feb; 134(2):84-9. PubMed ID: 4811013
    [No Abstract]   [Full Text] [Related]  

  • 7. [The hormone and chemotherapy in female metastatic breast cancer (author's transl)].
    Obrecht JP; Nagel GA; Mayr AC
    Schweiz Rundsch Med Prax; 1974 Jan; 63(4):109-14. PubMed ID: 4411163
    [No Abstract]   [Full Text] [Related]  

  • 8. [Current problems in the therapy of diffuse breast carcinoma].
    Di Pietro S
    Minerva Radiol; 1968 Oct; 13(10):569-73. PubMed ID: 5734810
    [No Abstract]   [Full Text] [Related]  

  • 9. [The current status of endocrine therapy in the palliative treatment of the metastasizing breast carcinoma in women].
    Nowakowski H
    Chirurg; 1968 Jun; 39(6):258-63. PubMed ID: 5697277
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormone therapy of breast cancer].
    Maass H
    Med Welt; 1976 May; 27(21):1047-51. PubMed ID: 180375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental and clinical aspects of hormone therapy in breast cancer (author's transl)].
    Maass H; Jonat W
    Arch Geschwulstforsch; 1981; 51(7):623-9. PubMed ID: 7337544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ablative endocrine treatment of advanced or metastasizing breast cancer. Criteria of patient selection].
    Bocci A; Campagnoli C
    Minerva Chir; 1976 Nov; 31(22):1371-6. PubMed ID: 1012556
    [No Abstract]   [Full Text] [Related]  

  • 13. [Management of metastasizing breast cancer].
    Braun E; Queisser W
    Fortschr Med; 1975 Dec; 93(35-36):1764-72. PubMed ID: 177341
    [No Abstract]   [Full Text] [Related]  

  • 14. [Simultaneous hormonal and drug therapy, compared to hormonal therapy, followed by chemotherapy, in the treatment of metastasizing breast neoplasms. Preliminary results of an ongoing study].
    Cavalli F; Alberto P; Jungi WF; Martz G; Barrelet L; Obrecht JP; Brunner KW
    Schweiz Med Wochenschr; 1978 Dec; 108(49):1964-6. PubMed ID: 749193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormonal therapy of metastizing breast cancer].
    von Werder K
    Med Klin; 1976 Feb; 71(8):313-21. PubMed ID: 56699
    [No Abstract]   [Full Text] [Related]  

  • 16. [Endocrine and cytostatic treatment of metastazing breast carcinoma in the female].
    Nowakowski H
    Strahlentherapie; 1974 Apr; 147(4):388-400. PubMed ID: 4409449
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hormone therapy and chemotherapy of metastasizing breast cancer. Experiences of the Basle Oncology Center, 1969-72].
    Byland W; Nagel G; Senn HJ
    Schweiz Med Wochenschr; 1974 Aug; 104(31):1077-85. PubMed ID: 4445838
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical management of metastatic breast cancer.
    Lawrence W; Brown PW; Terz JJ
    Surgery; 1977 Aug; 82(2):173-81. PubMed ID: 69328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women.
    Klaassen DJ; Rapp EF; Hirte WE
    Cancer Treat Rep; 1976 Mar; 60(3):251-3. PubMed ID: 1260780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
    Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
    Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.